Diabetes and Endocrinology - Global Cardiology Academy

17-25 of 25

Improving Symptoms, Function, and Weight Loss in HFpEF Patients with Obesity
Improving Symptoms, Function, and Weight Loss in HFpEF Patients with Obesity
Heart Matters
Improving Symptoms, Function, and Weight Loss in HFpEF Patients with Obesity
Mary Katherine Cheeley, PharmD, BCPS, CLS, FNLA; Javed Butler, MD
- Mary Katherine Cheeley, PharmD, BCPS, CLS, FNLA
- Javed Butler, MD
Closing Gaps in Care for Patients with T2D & CV Disease
Closing Gaps in Care for Patients with T2D & CV Disease
Diabetes Discourse
Closing Gaps in Care for Patients with T2D & CV Disease
John Buse, MD, PhD; Jennifer B. Green, MD
- John Buse, MD, PhD
- Jennifer B. Green, MD
What to Know About the No Surprises Act
What to Know About the No Surprises Act
Perspectives with the AMA
What to Know About the No Surprises Act
Charles Turck, PharmD, BCPS, BCCCP; Emily Carroll, JD, MSW
- Charles Turck, PharmD, BCPS, BCCCP
- Emily Carroll, JD, MSW
Assessing Glucose Control & Reducing Cardiovascular Risk in Patients with Diabetes
Assessing Glucose Control & Reducing Cardiovascular Risk in Patients with Diabetes
Diabetes Discourse
Assessing Glucose Control & Reducing Cardiovascular Risk in Patients with Diabetes
John E. Anderson, MD; Simon Heller, MD
- John E. Anderson, MD
- Simon Heller, MD
Hypoglycemia & the Cardiovascular System: An Inside Look at Emerging Clinical Trial Data
Hypoglycemia & the Cardiovascular System: An Inside Look at Emerging Clinical Trial Data
Diabetes Discourse
Hypoglycemia & the Cardiovascular System: An Inside Look at Emerging Clinical Trial Data
John E. Anderson, MD; Simon Heller, MD
- John E. Anderson, MD
- Simon Heller, MD
Dissecting Clinical Trial Data from the 81^st Scientific Sessions
Dissecting Clinical Trial Data from the 81^st Scientific Sessions
Diabetes Discourse
Dissecting Clinical Trial Data from the 81^st Scientific Sessions
John E. Anderson, MD; John Buse, MD, PhD
- John E. Anderson, MD
- John Buse, MD, PhD
- Carol Wysham, MD
Investigating SGLT-2 Inhibitors in Diabetes: Considerations & Conversation
Investigating SGLT-2 Inhibitors in Diabetes: Considerations & Conversation
Diabetes Discourse
Investigating SGLT-2 Inhibitors in Diabetes: Considerations & Conversation
John Buse, MD, PhD; Anne Louise Peters, MD
- John Buse, MD, PhD
- Anne Louise Peters, MD
Detecting & Diagnosing Diabetes in Cardiology Patients
Detecting & Diagnosing Diabetes in Cardiology Patients
Heart Matters
Detecting & Diagnosing Diabetes in Cardiology Patients
Matthew J. Sorrentino, MD, FACC, FASH; Alan S. Brown, MD, FACC, FAHA, FNLA
- Matthew J. Sorrentino, MD, FACC, FASH
- Alan S. Brown, MD, FACC, FAHA, FNLA
A Look at Diabetes Drugs That Reduce the Risk of Cardiovascular Disease
A Look at Diabetes Drugs That Reduce the Risk of Cardiovascular Disease
The Drug Report
A Look at Diabetes Drugs That Reduce the Risk of Cardiovascular Disease
Linda Bernstein, Pharm.D.
- Linda Bernstein, Pharm.D.

Previous
1
2
Next

2/2